<DOC>
	<DOCNO>NCT01899040</DOCNO>
	<brief_summary>This randomize , blind study design assess efficacy portable , non-invasive neuromodulation system treatment episodic migraine headache .</brief_summary>
	<brief_title>A Non-Invasive Neuromodulation Device Treatment Migraine Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>INCLUSION CRITERIA : The patient must diagnose episodic Migraine Headache least 6 month prior enter Study , consistent International Headache Classification Headache DisordersII ( ICHDII ) guideline . The patient must history least three consecutive month stable Migraine Headaches prior enter Study . The patient change medication usage three Months lead Study , introduce new medication Study period . Patients satisfy criterion : On Monthly basis , least four , total fourteen ( 414 ) , Headache Days ( Pain Score one ten ) four nine ( 414 ) Migraine Headache Days The patient must fail two class properly administer prophylactic pharmaceutical therapy migraine headache . The patient may single migraine prophylactic long dosage alter within 3 month start study dosage must alter duration study . The Investigator must confidence patient 's ability reliably use Experimental Device promptly complete Daily Headache Diary form . The Daily Headache Diary complete begin PreTreatment Baseline Period end Pivotal Study . EXCLUSION CRITERIA : Individuals : pregnant history cardiovascular disease work night shift diagnose vestibular migraine diagnose migraine aura menstrual migraine exclusively diagnose posttraumatic migraine history unstable mood disorder unstable anxiety disorder use hearing aid cochlear implant chronic tinnitus temporomandibular joint disease diagnose traumatic brain injury diagnose neurological disease Headaches diagnose vestibular dysfunction abuse alcohol drug experience medication overuse Headaches ( individual respect Investigator concerned analgesic abuse involve base ICHDII guideline ) . le 18 year old great 65 year old eye surgery within previous three month ear surgery within previous six month active ear infection perforate tympanic membrane participate another clinical trial within last 30 day currently enrol another clinical trial use Botox treatment migraine Though exclude , patient take antihistamine antinausea drug encourage take medication within four hour prior use Device . The Investigator review medication take patient property mimic antinausea antidizziness drug may reduce responsiveness stimulation . Such medication also avoid within four hour prior treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>neuromodulation</keyword>
	<keyword>migraine headache</keyword>
</DOC>